 |
Click HERE for details on the Oligo Fund
Search Term: Oligodendroglioma High Grade
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!
Trials and Noteworthy Treatments
|
|
|
|
|
|
Treatment Next 25
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor (Toca 511) |
|
Los Angeles, CA
Detroit, MI
Edison, NJ
Columbus, OH
Seattle, WA |
|
02/01/2012 |
|
|
|
|
|
Details |
|
Phase I Clinical Trial Evaluating Cellular Immunotherapy With Intratumoral Alloreactive Cytotoxic T Lymphocytes and Interleukin-2 for the Treatment of Recurrent Malignant Gliomas |
|
Los Angeles, CA |
|
10/27/2011 |
|
|
|
Details |
|
RTOG 0834: Phase III trial on Concurrent and Adjuvant Temozolomide chemotherapy in non - 1p/19q deleted anaplastic glioma. The CATNON Intergroup trial. |
|
Houston, TX |
|
05/11/2011 |
|
|
|
|
|
Details |
|
A Phase I Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide ISA-51VG in Pediatric Patients With Recurrent or Refractory Central Nervous System Tumors |
|
New York, NY |
|
03/10/2011 |
|
|
|
Details |
|
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, followed by Dose Dense Therapy with Temozolomide Plus Bevacizumab (Avastin) for Newly Diagnosed Malignant High Grade Gliomas |
|
Houston, TX |
|
12/20/2010 |
|
|
|
|
|
Details |
|
Lenalidomide and Radiation Therapy in Treating Young Patients With Pontine Glioma or High-Grade Glioma |
|
Bethesda, MD |
|
11/08/2010 |
|
|
|
Details |
|
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain
|
|
San Francisco, CA |
|
11/04/2010 |
|
|
|
|
|
Details |
|
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas |
|
Duarte, CA |
|
10/22/2010 |
|
|
|
Details |
|
Dendritic Cell Vaccine for Patients With Brain Tumors |
|
Los Angeles, CA |
|
09/21/2010 |
|
|
|
|
|
Details |
|
A Phase II Study of PDGFR Kinase Inhibitor (Tasigna® - nilotinib) in Biomarker-Enriched Recurrent Malignant Gliomas
|
|
La Jolla, CA |
|
08/17/2010 |
|
|
|
Details |
|
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. |
|
Rochester, NY |
|
04/13/2010 |
|
|
|
|
|
Details |
|
A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors |
|
San Francisco, CA |
|
04/12/2010 |
|
|
|
Details |
|
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
03/30/2010 |
|
|
|
|
|
Details |
|
2006-0472: Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
2009-0651: Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
ID01-310: Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
NABTC04-03: Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
NABTC0701: Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
03/29/2010 |
|
|
|
Details |
|
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
|
Los Angeles, CA |
|
01/24/2010 |
|
|
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
01/24/2010 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
|
Los Angeles, CA
Los Angeles, CA |
|
01/24/2010 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Jacksonville, FL
Ames, IA
Cedar Rapids, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Lambertville, MI
Duluth, MN
Saint Louis Park, MN
Billings, MT
Bismarck, ND
Lincoln, NE
Allentown, PA
Danville, PA
Sayre, PA
Spartanburg, SC
Rapid City, SD
Sioux Falls, SD |
|
01/12/2010 |
|
|
|
Details |
|
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
01/11/2010 |
|
|
|
|
|
Details |
|
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
|
San Francisco, CA |
|
01/11/2010 |
|
|
|
Details |
|
A PHASE II STUDY OF GLIADEL, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT HIGH GRADE GLIOMA |
|
Cincinnati, OH |
|
12/02/2009 |
|
|
|
|
|
News Stories
Frequently Asked Questions
|
|
